SLC6A3 and craniodiaphyseal dysplasia: Since a recent study has demonstrated that inhibiting the dopamine transporter with methylphenidate rescues the hyperactivity in a CDD mouse model,54 it may be interesting in future studies to assess FRAX486 treatment effects on the defective dopaminergic system in CDD mouse brain.